select search filters
roundups & rapid reactions
before the headlines
Fiona fox's blog

COV-BOOST results on fourth dose vaccine immune responses

A new study from the COV-BOOST trial looking at fourth doses of COVID-19 vaccine has been published in the Lancet Infectious Diseases.

The study examines safety and immune response (antibodies and T-cells) after a fourth dose of mRNA COVID-19 vaccine, and compares immune response after a fourth dose with that after a third dose.  In the study, 166 people who had received a third dose of Pfizer (following Pfizer or AstraZeneca initial doses in June 2021) were randomised to receive either full dose Pfizer or half dose Moderna as a fourth dose.

Journalists dialled in to this briefing to hear from authors of the study describe and explain their results.


Speakers included:

Prof Saul Faust, COV-BOOST Chief Investigator and NISEC co-investigator, and Director of NIHR Southampton Clinical Research Facility and Professor of Paediatric Immunology and Infectious Diseases at the University of Southampton

in this section

filter Briefings by year

search by tag